[Hyperandrogenism in premenopausal women]

Area of Science:

• Endocrinology
• Reproductive Health
• Steroid Hormone Biology

Background:

• Androgens, steroid hormones from adrenal glands and ovaries, play crucial roles in female physiology.
• Adrenal androgen secretion increases significantly around age 7 and continues until puberty.
• Excess androgens can stem from idiopathic adrenal hyperandrogenism or late-onset congenital adrenal hyperplasia.

Purpose of the Study:

• To differentiate causes of hyperandrogenism in women.
• To evaluate treatment efficacy for conditions like acne and hirsutism.
• To clarify diagnostic approaches for polycystic ovary syndrome (PCOS).

Main Methods:

• Dexamethasone suppression testing to assess adrenal androgen production.
• Measurement of 17-hydroxyprogesterone for diagnosing 21-hydroxylase deficiency.
• Hormonal assays including testosterone, androstenedione, and luteinizing hormone (LH).
• Ovarian ultrasonography for assessing PCOS morphology.

Main Results:

• Dexamethasone can block dehydroepiandrosterone sulfate (DHEAS) production, ruling out adrenal tumors.
• Dexamethasone is effective for acne but not hirsutism, which necessitates antiandrogens.
• Late-onset 21-hydroxylase deficiency is diagnosed via 17-hydroxyprogesterone and responds well to dexamethasone.
• PCOS diagnosis relies on hormonal profiles (elevated testosterone, androstenedione, LH) and clinical signs like anovulation and hirsutism.

Conclusions:

• Hyperandrogenism in women has diverse origins, including adrenal and ovarian sources.
• Accurate diagnosis through hormonal assessment is key to effective treatment.
• Combined therapeutic strategies, including antiandrogens and adrenal suppression, are often required for optimal outcomes.